A 12-wk follow-up study to evaluate the effects of mixing insulin lispro and insulin glargine in young individuals with type 1 diabetes

A 12-wk follow-up study to evaluate the effects of mixing insulin lispro and insulin glargine in young individuals with type 1 diabetes

Autor Lucchesi, Maria B. B. Autor UNIFESP Google Scholar
Komatsu, William R. Autor UNIFESP Google Scholar
Gabbay, Monica A. L. Autor UNIFESP Google Scholar
Dib, Sergio A. Autor UNIFESP Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Resumo Objective: This study was performed to compare in real-life conditions the serum profile of insulin lispro (IL) after a subcutaneous (SC) injection, separate and mixed with insulin glargine (IG), using a sensitive radioimmunoassay for the specific determination of serum IL, and to evaluate the 12-wk effect of the mixture on glycemic control in young individuals with type 1 diabetes.Research design and methods: the IL serum profiles were evaluated in 10 individuals with type 1 diabetes [age 21.9 +/- 3.8 yr; diabetes duration 13.4 +/- 4.9 yr; body mass index 25.1 +/- 3.2 kg/m(2); hemoglobin A1c (HbA1c) 8.3 +/- 0.8%] during a mixed meal test (MMT) using IL and IG as separate (baseline) and mixed injection. the glycemic variability by continuous glucose monitoring system (CGMS) and the long-term diabetes control with HbA1c were also evaluated at baseline and after 12 wk mixing the two insulins.Results: the mixture of IL with IG decreased IL maximum serum concentration (C-maxIL) (29.4 +/- 5.1 mu U/mL vs. 13.7 +/- 4.2 mu U/mL; p = 0.03) without changing the time to reach the Cmax (T-maxIL), the IL area under the curve (AUC(IL0-240)), and the glucose dynamics during the MMT. the glucose variability and the HbA1c were equivalent to baseline after 12 wk mixing both insulins.Conclusions: These data suggest that mixing IL with IG immediately before the SC injection decreases IL serum peak concentration without affecting the glycemic profile after 12 wk in this group with type 1 diabetes mellitus.
Palavra-chave glycemic variability and glucose control
insulin analogs
insulin levels
Idioma Inglês
Financiador Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Data de publicação 2012-11-01
Publicado em Pediatric Diabetes. Hoboken: Wiley-Blackwell, v. 13, n. 7, p. 519-524, 2012.
ISSN 1399-543X (Sherpa/Romeo, fator de impacto)
Publicador Wiley-Blackwell
Extensão 519-524
Fonte http://dx.doi.org/10.1111/j.1399-5448.2012.00867.x
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:000310551600002
Endereço permanente http://repositorio.unifesp.br/handle/11600/35485

Exibir registro completo


Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções



Minha conta